Lexicon Pharmaceuticals I... (LXRX)
NASDAQ: LXRX
· Real-Time Price · USD
1.24
0.06 (5.08%)
At close: Aug 15, 2025, 3:59 PM
1.23
-0.40%
After-hours: Aug 15, 2025, 07:58 PM EDT
Lexicon Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 58.43M | 31.21M | 31.08M | 5.23M | 3.64M | 2.31M | 1.21M | 531K | 408K | 126K | 139K | 125K | 109K | 308K | 298K | 483K | 7.09M | 16.02M |
Cost of Revenue | 658K | 615K | 760K | 629K | 565K | 407K | 344K | 230K | 331K | 430K | 427K | 16.82M | 32.4M | 42.55M | 55.05M | 38.55M | 23.5M | 13.97M |
Gross Profit | 57.77M | 30.6M | 30.32M | 4.6M | 3.08M | 1.9M | 861K | 301K | 77K | -304K | -288K | -16.7M | -32.29M | -42.24M | -54.75M | -38.07M | -16.41M | 2.05M |
Operating Income | -118.37M | -177.46M | -197.12M | -211.12M | -197.06M | -185.94M | -171.75M | -155.29M | -128.75M | -108.52M | -100.76M | -95.81M | -95.68M | -89.63M | -87.09M | -69.22M | 40.42M | -6.2M |
Interest Income | 8.11M | 10.41M | 12.29M | 11.87M | 11.43M | 8.59M | 7.73M | 6.22M | 3.78M | 2.61M | 1.6M | 723K | 162K | 100K | 134K | 995K | 1.28M | 1.86M |
Pretax Income | -120.62M | -177.3M | -200.4M | -214.88M | -200.59M | -192.07M | -175.61M | -157.86M | -130.72M | -110.4M | -101.94M | -97.06M | -96.8M | -90.28M | -87.76M | -67.64M | 38.08M | -12.92M |
Net Income | -120.62M | -177.3M | -200.4M | -214.88M | -200.59M | -192.07M | -174.58M | -157.04M | -130.2M | -110.46M | -103.13M | -98.03M | -97.47M | -90.37M | -87.76M | -67.64M | 38.08M | -12.92M |
Selling & General & Admin | 92.81M | 122.65M | 143.1M | 143.45M | 136.09M | 126.9M | 113.98M | 97.7M | 78.05M | 58.73M | 48.08M | 40.6M | 35.33M | 32.58M | 32.34M | 29.93M | 34.62M | 40.8M |
Research & Development | 83.34M | 85.41M | 84.34M | 72.27M | 64.04M | 60.94M | 58.74M | 58.1M | 51.1M | 49.92M | 52.82M | 55.34M | 60.46M | 57.36M | 55.05M | 39.54M | 64M | 111.05M |
Other Expenses | n/a | n/a | n/a | 112K | 112K | 112K | 112K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 176.29M | 208.21M | 227.58M | 215.72M | 200.13M | 187.84M | 172.72M | 155.81M | 129.16M | 108.65M | 100.9M | 95.94M | 95.79M | 89.94M | 87.39M | 69.47M | 98.63M | 151.85M |
Interest Expense | 8.9M | 8.8M | 15.58M | 17.14M | 16.48M | 16.23M | 13.1M | 8.78M | 5.75M | 4.49M | 2.78M | 1.97M | 1.28M | 745K | 802K | 677K | 4.62M | 9.58M |
Selling & Marketing Expenses | n/a | n/a | n/a | -74.09M | -44.42M | -44.42M | -27.5M | 52.24M | 33.44M | 33.44M | 16.51M | 11.78M | 910K | 910K | 910K | 6.38M | 6.38M | 6.38M |
Cost & Expenses | 176.81M | 208.68M | 228.2M | 216.35M | 200.7M | 188.25M | 172.96M | 155.82M | 129.16M | 108.65M | 100.9M | 95.94M | 95.79M | 89.94M | 87.39M | 69.47M | 99.26M | 153.21M |
Income Tax Expense | -101K | -101K | -276 | -2.88M | -2.88M | -2.88M | -4.01M | -813K | -521K | 59K | 1.18M | 954K | 572K | 11K | -37K | -23K | 67K | 48K |
Shares Outstanding (Basic) | 363.29M | 362.07M | 361.49M | 361.49M | 310.84M | 245.39M | 244.93M | 244.93M | 204.78M | 189.01M | 188.73M | 174.9M | 149.62M | 149.15M | 148.9M | 145.82M | 144.45M | 143.38M |
Shares Outstanding (Diluted) | 363.57M | 362.07M | 361.49M | 361.49M | 310.84M | 245.39M | 244.93M | 244.93M | 204.78M | 189.01M | 188.73M | 174.9M | 149.62M | 149.15M | 148.9M | 145.82M | 144.45M | 143.38M |
EPS (Basic) | -0.33 | -0.51 | -0.64 | -0.75 | -0.78 | -0.83 | -0.79 | -0.75 | -0.68 | -0.63 | -0.63 | -0.64 | -0.66 | -0.62 | -0.61 | -0.48 | 0.45 | -0.07 |
EPS (Diluted) | -0.33 | -0.51 | -0.64 | -0.75 | -0.78 | -0.83 | -0.79 | -0.75 | -0.68 | -0.63 | -0.63 | -0.64 | -0.66 | -0.62 | -0.61 | -0.48 | 0.39 | -0.13 |
EBITDA | -109.84M | -166.66M | -185.44M | -199.84M | -186.19M | -177.92M | -163.46M | -148.56M | -124.5M | -105.48M | -98.74M | -94.65M | -95.09M | -89.17M | -86.66M | -66.44M | 43.91M | -1.28M |
EBIT | -110.27M | -167.05M | -185.97M | -200.4M | -186.78M | -178.5M | -164.02M | -149.07M | -124.97M | -105.91M | -99.16M | -95.09M | -95.52M | -89.53M | -86.96M | -66.97M | 42.71M | -3.34M |
Depreciation & Amortization | 603K | 566K | 534K | 556K | 581K | 586K | 554K | 510K | 467K | 430K | 427K | 436K | 429K | 364K | 292K | 524K | 1.21M | 2.06M |